219 related articles for article (PubMed ID: 22122678)
1. Twenty years of Alzheimer's disease-causing mutations.
Goate A; Hardy J
J Neurochem; 2012 Jan; 120 Suppl 1():3-8. PubMed ID: 22122678
[TBL] [Abstract][Full Text] [Related]
2. Journal of Neurochemistry special issue on Alzheimer's disease: 'amyloid cascade hypothesis--20 years on'.
Checler F; Turner AJ
J Neurochem; 2012 Jan; 120 Suppl 1():iii-iv. PubMed ID: 22182264
[No Abstract] [Full Text] [Related]
3. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline.
Jonsson T; Atwal JK; Steinberg S; Snaedal J; Jonsson PV; Bjornsson S; Stefansson H; Sulem P; Gudbjartsson D; Maloney J; Hoyte K; Gustafson A; Liu Y; Lu Y; Bhangale T; Graham RR; Huttenlocher J; Bjornsdottir G; Andreassen OA; Jönsson EG; Palotie A; Behrens TW; Magnusson OT; Kong A; Thorsteinsdottir U; Watts RJ; Stefansson K
Nature; 2012 Aug; 488(7409):96-9. PubMed ID: 22801501
[TBL] [Abstract][Full Text] [Related]
4. The role of amyloid in the pathogenesis of Alzheimer's disease.
Verbeek MM; Ruiter DJ; de Waal RM
Biol Chem; 1997 Sep; 378(9):937-50. PubMed ID: 9348103
[TBL] [Abstract][Full Text] [Related]
5. Piecing together Alzheimer's.
St George-Hyslop PH
Sci Am; 2000 Dec; 283(6):76-83. PubMed ID: 11103462
[No Abstract] [Full Text] [Related]
6. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective.
Tanzi RE; Bertram L
Cell; 2005 Feb; 120(4):545-55. PubMed ID: 15734686
[TBL] [Abstract][Full Text] [Related]
7. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
8. APP transgenic modeling of Alzheimer's disease: mechanisms of neurodegeneration and aberrant neurogenesis.
Crews L; Rockenstein E; Masliah E
Brain Struct Funct; 2010 Mar; 214(2-3):111-26. PubMed ID: 20091183
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic processing of Alzheimer's β-amyloid precursor protein.
Zhang H; Ma Q; Zhang YW; Xu H
J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):9-21. PubMed ID: 22122372
[TBL] [Abstract][Full Text] [Related]
10. Role of the beta-amyloid precursor protein in Alzheimer's disease.
Ashall F; Goate AM
Trends Biochem Sci; 1994 Jan; 19(1):42-6. PubMed ID: 8140621
[TBL] [Abstract][Full Text] [Related]
11. Autosomal-dominant Alzheimer's disease mutations at the same codon of amyloid precursor protein differentially alter Aβ production.
Suárez-Calvet M; Belbin O; Pera M; Badiola N; Magrané J; Guardia-Laguarta C; Muñoz L; Colom-Cadena M; Clarimón J; Lleó A
J Neurochem; 2014 Jan; 128(2):330-9. PubMed ID: 24117942
[TBL] [Abstract][Full Text] [Related]
12. Distinguishable effects of presenilin-1 and APP717 mutations on amyloid plaque deposition.
Ishii K; Lippa C; Tomiyama T; Miyatake F; Ozawa K; Tamaoka A; Hasegawa T; Fraser PE; Shoji S; Nee LE; Pollen DA; St George-Hyslop PH; Ii K; Ohtake T; Kalaria RN; Rossor MN; Lantos PL; Cairns NJ; Farrer LA; Mori H
Neurobiol Aging; 2001; 22(3):367-76. PubMed ID: 11378241
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
[TBL] [Abstract][Full Text] [Related]
14. Genetic heterogeneity of gene defects responsible for familial Alzheimer disease.
Tanzi R; Gaston S; Bush A; Romano D; Pettingell W; Peppercorn J; Paradis M; Gurubhagavatula S; Jenkins B; Wasco W
Genetica; 1993; 91(1-3):255-63. PubMed ID: 8125274
[TBL] [Abstract][Full Text] [Related]
15. Shutting down Alzheimer's.
Wolfe MS
Sci Am; 2006 May; 294(5):72-9. PubMed ID: 16708491
[No Abstract] [Full Text] [Related]
16. The Protective A673T Mutation of Amyloid Precursor Protein (APP) in Alzheimer's Disease.
Xia Q; Yang X; Shi J; Liu Z; Peng Y; Wang W; Li B; Zhao Y; Xiao J; Huang L; Wang D; Gao X
Mol Neurobiol; 2021 Aug; 58(8):4038-4050. PubMed ID: 33914267
[TBL] [Abstract][Full Text] [Related]
17. Familial L723P Mutation Can Shift the Distribution between the Alternative APP Transmembrane Domain Cleavage Cascades by Local Unfolding of the Ε-Cleavage Site Suggesting a Straightforward Mechanism of Alzheimer's Disease Pathogenesis.
Bocharov EV; Nadezhdin KD; Urban AS; Volynsky PE; Pavlov KV; Efremov RG; Arseniev AS; Bocharova OV
ACS Chem Biol; 2019 Jul; 14(7):1573-1582. PubMed ID: 31180641
[TBL] [Abstract][Full Text] [Related]
18. [Alzheimer's dementia and amyloid precursor-protein].
Blom N; Linnemann D
Ugeskr Laeger; 1992 Apr; 154(15):1010-5. PubMed ID: 1566508
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease aetiology: amyloid and chromosome 14.
Houlden H; Mullan M
Br J Hosp Med; 1993 Apr 21-May 4; 49(8):535-6. PubMed ID: 8508237
[No Abstract] [Full Text] [Related]
20. Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.
Betts V; Leissring MA; Dolios G; Wang R; Selkoe DJ; Walsh DM
Neurobiol Dis; 2008 Sep; 31(3):442-50. PubMed ID: 18602473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
